Postoperative Acute Intracranial Hemorrhage and Venous Thromboembolism in Patients with Brain Metastases Receiving Acetylsalicylic Acid Perioperatively
Current Oncology · 2024
DOI: 10.3390/curroncol31080343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Nikolay Tonchev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Otto-von-Guericke-University Magdeburg, Leipziger Straße 44, 39120 Magdeburg, Germany. Hauptthemen laut MEDLINE: Aspirin, Brain Neoplasms, Venous Thromboembolism, Intracranial Hemorrhages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Cranial operations are associated with a high risk of postoperative intracranial hemorrhage (pICH) and venous thromboembolic events, along with increased mortality and morbidity. With the use of acetylsalicylic acid (ASA) for prophylaxis becoming more prevalent, the risk of bleeding when ASA is administered preoperatively is unknown, as are the effects of discontinuation upon the occurrence of thromboembolic events, especially in societies with aging demographics. To address these questions, a retrospective analysis was performed using medical records and radiological images of 1862 patients subjected to brain tumor surgery over a decade in our department. The risk of pICH was compared in patients with metastases receiving ASA treatment versus patients not receiving ASA treatment. The occurrence of venous thromboembolic events after surgery was also evaluated. The study group consisted of 365 patients with different types of brain metastases. In total, 20 patients suffered pICH and 7 of these were associated with clinical neurological deterioration postoperatively. Of the 58 patients who took ASA preoperatively, 2 patients experienced pICH, compared with 5 patients in the non-ASA impact group (p = 0.120). Patients who took ASA were not at significantly higher risk of pICH and therefore a worse outcome compared to the group without ASA. Therefore, these data suggest that in patients at high cardiovascular risk, ASA can be safely continued during elective brain tumor surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Otto-von-Guericke-University Magdeburg, Leipziger Straße 44, 39120 Magdeburg, Germany.
ORCID-Profile: Nikolay Tonchev, Claudia A Dumitru
Zitieren
APA
Tonchev, N., Pinchuk, A., Dumitru, C. A., Neyazi, B., Swiatek, V. M., Stein, K. P., Sandalcioglu, I. E., & Rashidi, A. (2024). Postoperative Acute Intracranial Hemorrhage and Venous Thromboembolism in Patients with Brain Metastases Receiving Acetylsalicylic Acid Perioperatively. Current Oncology. https://doi.org/10.3390/curroncol31080343
Vancouver
Tonchev N, Pinchuk A, Dumitru CA, Neyazi B, Swiatek VM, Stein KP, et al. Postoperative Acute Intracranial Hemorrhage and Venous Thromboembolism in Patients with Brain Metastases Receiving Acetylsalicylic Acid Perioperatively. Current Oncology. 2024. doi:10.3390/curroncol31080343
BibTeX
@article{Tonchev2024,
author = {Tonchev, Nikolay and Pinchuk, Anatoli and Dumitru, Claudia A and Neyazi, Belal and Swiatek, Vanessa Magdalena and Stein, Klaus Peter and Sandalcioglu, Ibrahim Erol and Rashidi, Ali},
title = {Postoperative Acute Intracranial Hemorrhage and Venous Thromboembolism in Patients with Brain Metastases Receiving Acetylsalicylic Acid Perioperatively},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31080343}
}
EUVIMED